Simulation of the lipophilic and antigenic cores of the Aβ(1-42) peptide of Alzheimer's disease

Molecular Simulation

Volumn 27, Issue 4, 2001, Pages 237-242

  Mager, Peter P ^a   Fischer, Katrin ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Alzheimer's disease; A (1 42) peptide; Lipophilic cores

Indexed keywords

EID: 0010554714     PISSN: 08927022     EISSN: None     Source Type: Journal    
DOI: 10.1080/08927020108027949     Document Type: Article

References (11)

1. Barrow, C. J., Kenny, P. T. M., Ykikazu, A. and Zagorski, M. G. (1992). Solution conformations and aggregational properties of synthetic amyloid β-peptides of Alzheimer's disease, J. Mol. Biol., 225, 1075-1093.
2. Butterfield, D. H., Aksenov, M., Aksenova, M., Carney, J. M., Cole, P., Hall, N., Harris, M. E., Hensley, K., Howard, B. J., LaFontaine, M., Subramaniam, R. and Yatin, S. (1997). β-amyloid-derived free radical oxidation: a fundamental process in Alzheimer's disease, In: Molecular Mechanisms of Dementia, Wasco, N. and Tansi, R. E. Eds., Human Press, Totowa, NJ, 145-167.
3. Hilbich, C., Beyreuther, K., Hilbich, C., Kisters-Wolke, B., Masters, C. L. and Reed, J. (1991). Aggregation and secondary structure of synthetic amyloid βA4 peptide of Alzheimer's disease, J. Mol. Biol., 218, 149-163.
4. Kyte, J. and Doolite, R. F. (1982). Simple method for displaying the hydrophobic character of a protein, J. Mol. Biol., 157, 105-132.
5. Mager, P. P. (1998). Molecular simulation of the amylod β-peptide Aβ(1-40) of Alzheimer's disease, Mol. Simul., 20, 201-222.
6. Selkoe, D. J. (1994). Normal and abnormal biology of the β-amyloid precursor protein, Ann. Rev. Neurosci., 17, 489-517.
7. Shao, H., Marcinowski, K. J., Clancy, E. L., Salomon, A. R. and Zagorski, M. G. (1997). The solution structures of the β-amyloid peptide provide a molecular approach for the treatment of Alzheimer's disease, In: Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Eds. Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. and Wisniewski, H. M., Wiley, New York, pp. 729-735.
8. Simmonis, L. W., Becker, G. W., Brems, D. N., Brigham, E. F., Fuson, K. S., Li, W. Y., Lieberburg, I., May, P. C., Reydel, R. E., Tomaselli, K. J. and Wright, S. (1994). Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro, Mol. Pharmacol., 45, 373-379.
9. Soto, C. and Frangione, B. (1997). Inhibition of Alzheimer's amyloidogenesis by anti-β-sheet peptides, In: Alzheimer's Disease: Biology, Diagnosis and Therapeutics, Eds. Iqbal, K., Winblad, B., Nishimura, T., Takeda, M. and Wisniewski, H. M., Wiley, New York, pp. 711-716.
10. Terzi, E., Holzemann, G. and Seelig, J. (1994). Alzheimer beta-amyloid peptide: electrostatic interactions with phospholipid membranes, Biochemistry, 33, 7431-7441.
11. Welling, G. W., Weijer, W. J., van der Zee, R. and Welling-Wester, S. (1985). Prediction of the sequential regions in proteins, FEBS Lett., 188, 215-218.